Ann & Robert H Lurie Children's Hospital of Chicago Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2015
NCT02455245
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Chair, Pritzker Department of Psychiatry and Behavioral Health

Active Ingredients

Drugs in Phase 3 Trials (2)

carboplatin (paraplatin) (1 trial)

vincristine (oncovin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glioma (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2